142 related articles for article (PubMed ID: 31518568)
1. Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene.
Honig MG; Del Mar NA; Henderson DL; Ragsdale TD; Doty JB; Driver JH; Li C; Fortugno AP; Mitchell WM; Perry AM; Moore BM; Reiner A
Exp Neurol; 2019 Dec; 322():113063. PubMed ID: 31518568
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast.
Honig MG; Del Mar NA; Henderson DL; O'Neal D; Yammanur M; Cox R; Li C; Perry AM; Moore BM; Reiner A
Exp Eye Res; 2022 May; 218():108966. PubMed ID: 35143834
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.
Guley NM; Del Mar NA; Ragsdale T; Li C; Perry AM; Moore BM; Honig MG; Reiner A
Exp Eye Res; 2019 May; 182():109-124. PubMed ID: 30922891
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene Modulates Microglia and Rescues Visual Deficits and Pathology After Impact Traumatic Brain Injury.
Honig MG; Del Mar NA; Henderson DL; O'Neal D; Doty JB; Cox R; Li C; Perry AM; Moore BM; Reiner A
Front Neurosci; 2021; 15():701317. PubMed ID: 34776838
[TBL] [Abstract][Full Text] [Related]
5. Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189.
Reiner A; Heldt SA; Presley CS; Guley NH; Elberger AJ; Deng Y; D'Surney L; Rogers JT; Ferrell J; Bu W; Del Mar N; Honig MG; Gurley SN; Moore BM
Int J Mol Sci; 2014 Dec; 16(1):758-87. PubMed ID: 25561230
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene Mitigates Emotional Deficits after Mild Traumatic Brain Injury in Mice.
Honig MG; Del Mar NA; Moore BM; Reiner A
Neurotrauma Rep; 2022; 3(1):534-544. PubMed ID: 36479361
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189.
Liu Y; McAfee SS; Guley NM; Del Mar N; Bu W; Heldt SA; Honig MG; Moore BM; Reiner A; Heck DH
eNeuro; 2017; 4(4):. PubMed ID: 28828401
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cannabinoid CB
Salort G; Álvaro-Bartolomé M; García-Sevilla JA
Psychopharmacology (Berl); 2017 Mar; 234(6):925-941. PubMed ID: 28127623
[TBL] [Abstract][Full Text] [Related]
9. Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist.
Bu W; Ren H; Deng Y; Del Mar N; Guley NM; Moore BM; Honig MG; Reiner A
Front Neurosci; 2016; 10():449. PubMed ID: 27766068
[TBL] [Abstract][Full Text] [Related]
10. Identification of raloxifene as a novel CB2 inverse agonist.
Kumar P; Song ZH
Biochem Biophys Res Commun; 2013 May; 435(1):76-81. PubMed ID: 23611779
[TBL] [Abstract][Full Text] [Related]
11. Concentrated Conditioned Media from Adipose Tissue Derived Mesenchymal Stem Cells Mitigates Visual Deficits and Retinal Inflammation Following Mild Traumatic Brain Injury.
Jha KA; Pentecost M; Lenin R; Klaic L; Elshaer SL; Gentry J; Russell JM; Beland A; Reiner A; Jotterand V; Sohl N; Gangaraju R
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29997321
[TBL] [Abstract][Full Text] [Related]
12. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
Yu Y; Li L; Nguyen DT; Mustafa SM; Moore BM; Jiang J
Mol Neurobiol; 2020 Jun; 57(6):2830-2845. PubMed ID: 32378121
[TBL] [Abstract][Full Text] [Related]
13. CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury.
Lopez-Rodriguez AB; Mela V; Acaz-Fonseca E; Garcia-Segura LM; Viveros MP
Exp Neurol; 2016 May; 279():274-282. PubMed ID: 27006282
[TBL] [Abstract][Full Text] [Related]
14. Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243.
Dutca LM; Stasheff SF; Hedberg-Buenz A; Rudd DS; Batra N; Blodi FR; Yorek MS; Yin T; Shankar M; Herlein JA; Naidoo J; Morlock L; Williams N; Kardon RH; Anderson MG; Pieper AA; Harper MM
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8330-41. PubMed ID: 25468886
[TBL] [Abstract][Full Text] [Related]
15. Systemic Elevation of n-3 Polyunsaturated Fatty Acids (n-3-PUFA) Is Associated with Protection against Visual, Motor, and Emotional Deficits in Mice following Closed-Head Mild Traumatic Brain Injury.
Mondal K; Takahashi H; Cole J; Del Mar NA; Li C; Stephenson DJ; Allegood J; Cowart LA; Chalfant CE; Reiner A; Mandal N
Mol Neurobiol; 2021 Nov; 58(11):5564-5580. PubMed ID: 34365584
[TBL] [Abstract][Full Text] [Related]
16. A Novel Closed-Head Model of Mild Traumatic Brain Injury Using Focal Primary Overpressure Blast to the Cranium in Mice.
Guley NH; Rogers JT; Del Mar NA; Deng Y; Islam RM; D'Surney L; Ferrell J; Deng B; Hines-Beard J; Bu W; Ren H; Elberger AJ; Marchetta JG; Rex TS; Honig MG; Reiner A
J Neurotrauma; 2016 Feb; 33(4):403-22. PubMed ID: 26414413
[TBL] [Abstract][Full Text] [Related]
17. Visual Dysfunction after Repetitive Mild Traumatic Brain Injury in a Mouse Model and Ramifications on Behavioral Metrics.
Morriss NJ; Conley GM; Hodgson N; Boucher M; Ospina-Mora S; Fagiolini M; Puder M; Mejia L; Qiu J; Meehan W; Mannix R
J Neurotrauma; 2021 Oct; 38(20):2881-2895. PubMed ID: 34375128
[TBL] [Abstract][Full Text] [Related]
18. Adipose Tissue-Derived Mesenchymal Stem Cell Concentrated Conditioned Medium Alters the Expression Pattern of Glutamate Regulatory Proteins and Aquaporin-4 in the Retina after Mild Traumatic Brain Injury.
Jha KA; Gentry J; Del Mar NA; Reiner A; Sohl N; Gangaraju R
J Neurotrauma; 2021 Jun; 38(12):1702-1716. PubMed ID: 33183134
[TBL] [Abstract][Full Text] [Related]
19. A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Elliott MB
J Neurosci Res; 2012 Dec; 90(12):2293-305. PubMed ID: 22903455
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
Veenman L
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
